| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 68844-77-9 | Astemizole |
≥98% | | 询价 |
| 2 | 1642297-01-5 | GDC-0927 |
≥98% | | 询价 |
| 3 | 2140301-96-6 | PF-06700841 tosylate |
≥98% | | 询价 |
| 4 | 2097416-76-5 | AZD-0364 |
≥98% | | 询价 |
| 5 | 1000998-62-8 | BMS-711939 |
≥98% | | 询价 |
| 6 | 911715-90-7 | AZD8797 |
≥98% | | 询价 |
| 7 | 1204707-71-0 | SRT3109 |
≥98% | | 询价 |
| 8 | 1204707-73-2 | SRT3190 |
≥98% | | 询价 |
| 9 | 954126-98-8 | Danirixin |
≥98% | | 询价 |
| 10 | 473728-58-4 | SCH 563705 |
≥98% | | 询价 |
| 11 | 266359-83-5 | Reparixin |
≥98% | | 询价 |
| 12 | 266359-93-7 | Reparixin L-lysine salt |
≥98% | | 询价 |
| 13 | 473727-83-2 | Navarixin |
≥98% | | 询价 |
| 14 | 1873376-49-8 | CXCR2-IN-1 |
≥98% | | 询价 |
| 15 | 1038915-58-0 | Niraparib R-enantiomer |
≥98% | | 询价 |
| 16 | 1476777-06-6 | Niraparib metabolite M1 |
≥98% | | 询价 |
| 17 | 1038915-64-8 | Niraparib HCl(MK-4827) |
≥98% | | 询价 |
| 18 | 391611-36-2 | Spliceostatin A |
≥98% | | 询价 |
| 19 | 210826-40-7 | MCC950 |
≥98% | | 询价 |
| 20 | 288262-96-4 | BX-471 HCl |
≥98% | | 询价 |
| 21 | 1566517-83-6 | Q-203 Ditosylate |
≥98% | | 询价 |
| 22 | 269718-84-5 | Pardoprunox |
≥98% | | 询价 |
| 23 | 1005549-94-9 | Taprenepag isopropyl |
≥98% | | 询价 |
| 24 | 2070014-90-1 | LY303511 HCl |
≥98% | | 询价 |
| 25 | 154447-38-8 | LY303511 |
≥98% | | 询价 |
| 26 | 1795232-22-2 | LY3104607 |
≥98% | | 询价 |
| 27 | 1628607-64-6 | INCB054329 |
≥98% | | 询价 |
| 28 | 1912445-55-6 | BMS-986195 |
≥98% | | 询价 |
| 29 | 195532-12-8 | Pradofloxacin |
≥98% | | 询价 |
| 30 | 2135600-76-7 | LSZ102 |
≥98% | | 询价 |
| 31 | 1443983-36-5 | GDC-0927 Racemate |
≥98% | | 询价 |
| 32 | 65473-14-5 | Naftifine HCl(AW-105843 SN 105843) |
≥98% | | 询价 |
| 33 | 128311-08-0 | PNU-282987 S enantiomer hydrochloride |
≥98% | | 询价 |
| 34 | | 3-[N-(7'-nitrobenz-2'-oxa-1',3'-diazol-4'-yl)amino]propanic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 2220162-06-9 | NMDAR antagonist 1 |
≥98% | | 询价 |
| 36 | 175673-57-1 | MDL 100009(MDL100009) |
≥98% | | 询价 |
| 37 | 734517-40-9 | BRL15572 free base |
≥98% | | 询价 |
| 38 | 711085-63-1 | PNU282987 freebase |
≥98% | | 询价 |
| 39 | 866823-63-4 | Varenicline dihydrochloride |
≥98% | | 询价 |
| 40 | 119478-55-6 | Danofloxacin Mesylate(CP 76136-27) |
≥98% | | 询价 |
| 41 | 1265966-31-1 | S49076 HCl |
≥98% | | 询价 |
| 42 | 1009104-85-1 | SIS3 free base |
≥98% | | 询价 |
| 43 | 135028-15-8 | MK-571 sodium salt |
≥98% | | 询价 |
| 44 | 115104-28-4 | MK571(L660711) |
≥98% | | 询价 |
| 45 | 1239262-52-2 | Tubastatin A TFA |
≥98% | | 询价 |
| 46 | 1217449-45-0 | Aflatoxin B1-13C17 |
≥98% | | 询价 |
| 47 | 2628280-40-8 | Nirmatrelvir(PF-07321332) |
≥98% | | 询价 |
| 48 | 54573-75-0 | Doxercalciferol(1α-Hydroxyvitamin D2) |
≥98% | | 询价 |
| 49 | 1948273-02-6 | (S,R,S)-AHPC-Me |
≥98% | | 询价 |
| 50 | 101152-94-7 | Milnacipran HCl |
≥98% | | 询价 |
| 51 | 2243944-92-3 | Benzamide |
≥98% | | 询价 |
| 52 | 132465-11-3 | CDC lipoxygenase inhibitor |
≥98% | | 询价 |
| 53 | 95233-18-4 | Atovaquone(Atavaquone) |
≥98% | | 询价 |
| 54 | 405165-61-9 | Besifloxacin HCl |
≥98% | | 询价 |
| 55 | | MU1656 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | | PRN47 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 1453222-26-8 | SAH-EZH2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 35602-69-8 | Cholesteryl Stearate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | 68341-09-3 | CuATSM |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 60 | 2502156-03-6 | LC-2(LC2) |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com